Oct. 13, 2003 — Magnetic resonance cholangiopancreatography (MRCP) has excellent overall sensitivity and specificity for the level and presence of obstruction, but it is less sensitive in detecting ...
This session of the symposium addressed both the basics of ERCP interpretation as well as the newer trends in evaluating biliary anatomy by EUS, computed tomography (CT), and magnetic resonance ...
This article reviews the role of MRI in the evaluation of benign pancreatic disease. Although MRI and magnetic resonance cholangiopancreatography (MRCP) are most often used to evaluate the liver and ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Quantitative magnetic resonance cholangiopancreatography may help assess changes in the biliary tree ...
Perspectum Diagnostics released information on its MRCP+ noninvasive imaging technology at The Liver Meeting 2018, according to a press release. MRCP+ was designed to enhance and quantitatively ...
Ethiopia: Researchers have reported a rare case of a sigmoid gallbladder in a 38-year-old woman with gallstone disease. The ...
CBDS occur in 7-20% of all patients undergoing a gallstone operation and may complicate the course of surgery. Although intraoperative x-ray investigation was routinely performed to diagnose CBDS in ...
OXFORD, England--(BUSINESS WIRE)--Perspectum Diagnostics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MRCP+, the worlds most advanced ...
Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...
LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker means, how patterns point to causes, and when to seek further care.
Clinical and genomic characteristics of hepatocellular carcinoma-cholangiocarcinoma: Insights from real-world data. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results